ArticleMolecular therapy. Nucleic acids2023

MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway.

Taisuke Obata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.